Enhabit, Inc. (EHAB)
- Previous Close
9.87 - Open
9.84 - Bid 4.03 x 800
- Ask 10.07 x 1000
- Day's Range
9.80 - 10.10 - 52 Week Range
7.12 - 14.59 - Volume
224,345 - Avg. Volume
570,220 - Market Cap (intraday)
503.064M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-1.61 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
10.93
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.
www.ehab.com10,800
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: EHAB
Performance Overview: EHAB
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EHAB
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EHAB
Valuation Measures
Market Cap
503.06M
Enterprise Value
1.09B
Trailing P/E
--
Forward P/E
37.04
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.48
Price/Book (mrq)
0.75
Enterprise Value/Revenue
1.04
Enterprise Value/EBITDA
-65.80
Financial Highlights
Profitability and Income Statement
Profit Margin
-7.69%
Return on Assets (ttm)
1.61%
Return on Equity (ttm)
-10.70%
Revenue (ttm)
1.05B
Net Income Avi to Common (ttm)
-80.5M
Diluted EPS (ttm)
-1.61
Balance Sheet and Cash Flow
Total Cash (mrq)
27.4M
Total Debt/Equity (mrq)
87.13%
Levered Free Cash Flow (ttm)
49.2M
Research Analysis: EHAB
Company Insights: EHAB
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: EHAB
EHAB: Rating increased to a BUY
ENHABIT INC has an Investment Rating of BUY; a target price of $11.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of Low.
RatingPrice TargetEHAB: Lowering target price to $11.00
ENHABIT INC has an Investment Rating of HOLD; a target price of $11.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of Low.
RatingPrice TargetEHAB: Raising target price to $12.00
ENHABIT INC has an Investment Rating of HOLD; a target price of $12.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of Low.
RatingPrice TargetEHAB: Lowering target price to $11.00
ENHABIT INC has an Investment Rating of HOLD; a target price of $11.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice Target